Medindia

X

Brookdale to Present at Barclays Capital Global Healthcare Conference March 11

Friday, October 16, 2009 General News J E 4
Advertisement
NASHVILLE, Tenn., March 9 Brookdale Senior Living Inc. (NYSE: BKD) today announced that Bill Sheriff, Chief Executive Officer, and Mark Ohlendorf, Co-President and Chief Financial Officer, will make a presentation regarding the Company at the Barclays Capital Global Healthcare Conference in Miami Beach, Florida on Wednesday, March 11, 2009, beginning at 4:15 p.m. Eastern Time.

The presentation is being audio webcast live and can be accessed on the Internet at http://cc.talkpoint.com/barc002/030909a_rb/?entity=79_1YRC1YI as well as through the Investor Relations section of the Company's website at www.brookdaleliving.com. A replay of the webcast will be available on the Company's website for 30 days after the date of the presentation. The presentation slides will also be available during and after the presentation through the Investor Relations section of the Brookdale Senior Living website.

About Brookdale Senior Living

Brookdale Senior Living Inc. is a leading owner and operator of senior living communities throughout the United States. The Company is committed to providing an exceptional living experience through properties that are designed, purpose-built and operated to provide the highest-quality service, care and living accommodations for residents. Currently the Company owns and operates independent living, assisted living, and dementia-care communities and continuing care retirement centers, with 548 communities in 35 states and the ability to serve approximately 52,000 residents.

SOURCE Brookdale Senior Living Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Keryx Biopharmaceuticals, Inc. Requests an Appeal ...
S
Oncothyreon reports full year and fourth quarter 2...